Glypican-3–Targeting F(ab′)2 for 89Zr PET of Hepatocellular Carcinoma

Jonathan G. Sham; Forrest M. Kievit; John R. Grierson; Peter A. Chiarelli; Robert S. Miyaoka; Miqin Zhang; Raymond S. Yeung; Satoshi Minoshima; James O. Park

doi:10.2967/jnumed.114.145102

Research ArticleBasic Science Investigations

Glypican-3–Targeting F(ab′)2 for ⁸⁹Zr PET of Hepatocellular Carcinoma

Jonathan G. Sham, Forrest M. Kievit, John R. Grierson, Peter A. Chiarelli, Robert S. Miyaoka, Miqin Zhang, Raymond S. Yeung, Satoshi Minoshima and James O. Park

Journal of Nuclear Medicine December 2014, 55 (12) 2032-2037; DOI: https://doi.org/10.2967/jnumed.114.145102

Jonathan G. Sham

1Department of Surgery, University of Washington, Seattle, Washington

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Forrest M. Kievit

2Department of Neurological Surgery, University of Washington, Seattle, Washington

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

John R. Grierson

3Department of Radiology, University of Washington, Seattle, Washington; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Peter A. Chiarelli

2Department of Neurological Surgery, University of Washington, Seattle, Washington

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Robert S. Miyaoka

3Department of Radiology, University of Washington, Seattle, Washington; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Miqin Zhang

4Department of Materials Science & Engineering, University of Washington, Seattle, Washington

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Raymond S. Yeung

1Department of Surgery, University of Washington, Seattle, Washington

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Satoshi Minoshima

3Department of Radiology, University of Washington, Seattle, Washington; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

James O. Park

1Department of Surgery, University of Washington, Seattle, Washington

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Supplemental
Info & Metrics
PDF

Data supplements

Supplemental Data

Files in this Data Supplement:

Supplemental Data

PreviousNext

In this issue

Journal of Nuclear Medicine

Vol. 55, Issue 12

December 1, 2014

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Glypican-3–Targeting F(ab′)2 for 89Zr PET of Hepatocellular Carcinoma

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

Glypican-3–Targeting F(ab′)2 for ⁸⁹Zr PET of Hepatocellular Carcinoma

Jonathan G. Sham, Forrest M. Kievit, John R. Grierson, Peter A. Chiarelli, Robert S. Miyaoka, Miqin Zhang, Raymond S. Yeung, Satoshi Minoshima, James O. Park

Journal of Nuclear Medicine Dec 2014, 55 (12) 2032-2037; DOI: 10.2967/jnumed.114.145102

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Glypican-3–Targeting F(ab′)2 for ⁸⁹Zr PET of Hepatocellular Carcinoma

Jonathan G. Sham, Forrest M. Kievit, John R. Grierson, Peter A. Chiarelli, Robert S. Miyaoka, Miqin Zhang, Raymond S. Yeung, Satoshi Minoshima, James O. Park

Journal of Nuclear Medicine Dec 2014, 55 (12) 2032-2037; DOI: 10.2967/jnumed.114.145102

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Bookmark this article

User Name *

Password *

Remember my user name & password.

Jump to section

Article
Figures & Data
Supplemental
Info & Metrics
PDF

This Month in JNM

PubMed
Google Scholar

Cited By...

Glypican-3-Targeted 227Th {alpha}-Therapy Reduces Tumor Burden in an Orthotopic Xenograft Murine Model of Hepatocellular Carcinoma
Imaging Reveals Importance of Shape and Flexibility for Glomerular Filtration of Biologics
ImmunoPET as Stoichiometric Sensor for Glypican-3 in Models of Hepatocellular Carcinoma
Galectin-3 Targeting in Thyroid Orthotopic Tumors Opens New Ways to Characterize Thyroid Cancer

Google Scholar

Keywords

F(ab′)2
glypican-3
89Zr
positron emission tomography (PET)
hepatocellular carcinoma (HCC)

Main menu

User menu

Search

Glypican-3–Targeting F(ab′)2 for ⁸⁹Zr PET of Hepatocellular Carcinoma

Data supplements

Supplemental Data

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Keywords